Medication info
Ravisujeong

Ravisujeong

Prescription medicationTabletOral
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Round white film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201401486 · Approved 2014.03.31

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson syndrome before anesthesia
Who takes it
Adults
Adult dose
○ Adults Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to concomitant therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID treatment. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson syndrome before anesthesia

  • Gastric ulcer
  • duodenal ulcer
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • post-operative ulcers
  • NSAID-induced gastric ulcer
  • NSAID-induced duodenal ulcer
View approved original text

This medication is used to treat ulcers occurring in the stomach and duodenum, gastritis, and conditions such as Zollinger-Ellison syndrome. It is also effective for gastroesophageal reflux disease, and is administered to prevent Mendelson syndrome prior to surgery. It is suitable for ulcers occurring post-surgery and for gastric and duodenal ulcers induced by non-steroidal anti-inflammatory drugs (NSAIDs). In summary, it is used to improve various ulcer and inflammatory conditions related to the stomach and duodenum as well as pre and post-surgical states.

How to take

Adult dose

○ Adults Usually, regardless of meals, take 2 tablets orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Take 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The same dosage applies to concomitant therapy for ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) or to prevent gastric and duodenal ulcers during long-term NSAID treatment. Diseases caused by NSAID administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 2 tablets 3 times daily and increase the dose as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Preanesthetic medication (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with kidney dysfunction. It should also not be administered to patients with a history of allergic reactions to this medication or its ingredients, those with acute porphyria, patients who have undergone upper gastrointestinal surgery, women who are pregnant or may become pregnant, premature infants and newborns, and patients on a potassium-restricted diet. Patients with liver dysfunction, a history of drug allergies, elderly patients, those with past kidney issues, and patients taking NSAIDs should use this medication cautiously. In particular, as it may conceal symptoms of stomach cancer, it should be administered to gastric ulcer patients or middle-aged patients who have recently experienced new dyspeptic symptoms only after confirming they do not have malignant diseases. Patients with Helicobacter pylori infection with gastric or duodenal ulcers may require bacterial eradication therapy, and caution is necessary for critically ill patients in intensive care or those with hypophosphatemia and patients who have difficulty swallowing. This medication can rarely cause severe allergic reactions such as anaphylactic shock, so if abnormal symptoms occur during administration, discontinue use immediately and seek appropriate treatment. Skin rashes, hives, angioedema, fever, and bronchospasm are among the possible hypersensitivity reactions. Hematological abnormalities may also occur rarely, including leukopenia, thrombocytopenia, liver function abnormalities, hepatitis, arrhythmias, gastrointestinal disturbances, mental confusion, dizziness, drowsiness, myalgia, hair loss, and changes in stool color. If such abnormal symptoms appear, consult a doctor immediately to discontinue use or receive appropriate treatment. Avoid long-term use, and use the minimum dose while closely observing the treatment progress. Elderly patients or those with chronic pulmonary disease, diabetes, or weakened immune systems may have an increased risk of developing pneumonia. Activities requiring driving or operating dangerous machinery should be avoided in cases of dizziness or drowsiness. This medication may affect the absorption or metabolism of other drugs, particularly anticoagulants, certain antibiotics, and anticonvulsants, thus dose adjustments or changes in dosing intervals may be necessary when using them together. When taken with sucralfate, it should be administered with a gap of at least 2 hours to prevent absorption interference. It is safest for pregnant or breastfeeding women to avoid using this medication, and its safety in children has not been established, so it is advisable not to administer it to them. In case of overdose, treatment options may include inducing vomiting, gastric lavage, and blood dialysis if necessary. Finally, this medication reduces gastric acid secretion, which can promote the growth of bacteria in the stomach, and if used long-term, it may affect the eyes, so regular ophthalmic examinations may be necessary.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 59 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • bone marrow suppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • increased AST
  • increased ALT
  • increased r-GTP
  • increased ALP
  • cholestatic hepatitis
  • non-cholestatic hepatitis
  • tachycardia
  • bradycardia
  • atrioventricular block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucination
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • myoclonus
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • alopecia
  • stomatitis
  • pruritus
  • mucous membrane pemphigoid
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air from entering, and it is preferable to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness.

Appearance and packaging

Appearance

Round white film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.